Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs

被引：0
|
作者：
Janthima Methaneethorn
Kanyamas Naosang
Parichart Kaewworasut
Chomkanang Poomsaidorn
Manupat Lohitnavy
机构：
[1] Naresuan University,Pharmacokinetic Research Unit, Faculty of Pharmaceutical Sciences
[2] Naresuan University,Center of Excellence for Environmental Health and Toxicology
[3] Naresuan University,Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 494
页数：7
相关论文
共 50 条
  • [1] Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs
    Methaneethorn, Janthima
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Poomsaidorn, Chomkanang
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 487 - 494
  • [2] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Methaneethorn, Janthima
    Poomsaidorn, Chomkanang
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 495 - 511
  • [3] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Janthima Methaneethorn
    Chomkanang Poomsaidorn
    Kanyamas Naosang
    Parichart Kaewworasut
    Manupat Lohitnavy
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 495 - 511
  • [4] Pharmacokinetics and development of a physiologically-based pharmacokinetic model of docetaxel in mice
    Bradshaw-Pierce, Erica L.
    Merz, Andrea L.
    Zirrolli, Joseph A.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2006, 66 (08)
  • [5] Physiologically-based pharmacokinetic modeling of genistein in rats, part I: Model development
    Schlosser, PM
    Borghoff, SJ
    Coldham, NG
    David, JA
    Ghosh, SK
    RISK ANALYSIS, 2006, 26 (02) : 483 - 500
  • [6] The development of a stochastic physiologically-based pharmacokinetic model for lead
    Beck, BD
    Mattuck, RL
    Bowers, TS
    Cohen, JT
    O'Flaherty, E
    SCIENCE OF THE TOTAL ENVIRONMENT, 2001, 274 (1-3) : 15 - 19
  • [7] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ACETONE
    KUMAGAI, S
    MATSUNAGA, I
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (05) : 344 - 352
  • [8] DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF CANAGLIFLOZIN IN HUMANS.
    Courtois, K.
    Rower, J. E.
    Bradshaw-Pierce, E. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S35 - S35
  • [9] Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
    Ai, Jing
    Gao, Yunfeng
    Yang, Fan
    Zhao, Zhen
    Dong, Jin
    Wang, Jing
    Fu, Shiyi
    Ma, Ying
    Gu, Xu
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [10] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE ANTIBIOTIC ERTAPENEM
    Joyner, Michele L.
    Manning, Cammey C.
    Forbes, Whitney
    Maiden, Michelle
    Nikas, Ariel N.
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2016, 13 (01) : 119 - 133
12345